APA (7th ed.) Citation

SN, S., Q, X., Z, L., W, G., Y, C., J, L., . . . Y, F. (2026). ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 84, 101319. https://doi.org/10.1016/j.drup.2025.101319

Chicago Style (17th ed.) Citation

SN, Shi, et al. "ZBP1 Antagonizes MRE11-mediated DNA End Resection and Confers Synthetic Lethality to PARP Inhibition in Ovarian Cancer." Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 84 (2026): 101319. https://doi.org/10.1016/j.drup.2025.101319.

MLA (9th ed.) Citation

SN, Shi, et al. "ZBP1 Antagonizes MRE11-mediated DNA End Resection and Confers Synthetic Lethality to PARP Inhibition in Ovarian Cancer." Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, vol. 84, 2026, p. 101319, https://doi.org/10.1016/j.drup.2025.101319.